Cargando…
Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer
The aim of this study was to describe the type of risk-reducing gynaecologic surgery (RRGS) and the extent of pathological evaluation being undertaken for Australasian women at high familial risk of pelvic serous cancer. Surgical and pathology reports were reviewed for women with BRCA1/BRCA2 mutatio...
Autores principales: | Kiely, B. E., Friedlander, M. L., Milne, R. L., Stanhope, L., Russell, P., Jenkins, M. A., Weideman, P., McLachlan, S. A., Grant, P., Hopper, J. L., Phillips, K. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175342/ https://www.ncbi.nlm.nih.gov/pubmed/21424757 http://dx.doi.org/10.1007/s10689-011-9435-0 |
Ejemplares similares
-
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
por: McKinley, Joanne M, et al.
Publicado: (2007) -
Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
por: Phillips, KA, et al.
Publicado: (2012) -
Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer
por: Lee, Y. C., et al.
Publicado: (2017) -
Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence
por: Conduit, Ciara, et al.
Publicado: (2021) -
Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations
por: Phillips, Kelly-Anne, et al.
Publicado: (2016)